bioAffinity Technologies, Inc. Common Stock vs. NRC Health Common Stock
BIAF
bioAffinity Technologies, Inc. Common Stock
$10.45 +58.60%
VS NRCNRC Health Common Stock
$20.01 -2.10%
NRC Health Common Stock (NRC) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BIAF | NRC | |
|---|---|---|
| Market Cap | $3.90 million | $452.12 million |
| Revenue (TTM) | $5.90 million | — |
| Net Income (TTM) | $-15,185,242 | — |
NRC leads on 1 of 1 size & scale factors.
Valuation
| BIAF | NRC | |
|---|---|---|
| Price / Book | 1.04 | — |
| Price / Sales | 0.66 | — |
BIAF and NRC split the valuation factors evenly.
Profitability
| BIAF | NRC | |
|---|---|---|
| Net Margin | -257.33% | — |
| Return on Equity | -402.92% | — |
BIAF and NRC split the profitability factors evenly.
Dividend
| BIAF | NRC | |
|---|---|---|
| Dividend Yield | — | 3.20% |
BIAF and NRC split the dividend factors evenly.
Risk & Sentiment
| BIAF | NRC | |
|---|---|---|
| Short Interest | 1.46% | 0.43% |
NRC leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIAF overview, BIAF financials, NRC overview, NRC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.